Who benefits from portal vein resection during pancreaticoduodenectomy for pancreatic cancer?
Portal vein resection during pancreaticoduodenectomy has recently experienced renewed interest. We describe our results with this procedure over a 20-year period. Among 88 consecutive pancreatectomies for cancer of head of the pancreas, 14 included en bloc removal of the portal vein. There was no hospital mortality. Only 21% were found to have histologically confirmed cancer invasion, and the remainder had inflammatory adherence. Two-year survival was 15% compared to 34% for patients who did not have portal vein resection. There were no 5-year survivors. We discuss our results in light of other recent reports.
Launois
B
B
Department of Digestive Surgery and Hepatobiliary Unit, Centre Medico Chirurgical Saint-Vincent, and University of Rennes, Avenue Saint Vincent, B.P. 129, Saint Gregoire 35760, France.
Stasik
C
C
Bardaxoglou
E
E
Meunier
B
B
Campion
J P
JP
Greco
L
L
Sutherland
F
F
D000230:Adenocarcinoma / Q000401:mortality / Q000601:surgery*; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000401:mortality / Q000601:surgery*; D016577:Pancreaticoduodenectomy; D011169:Portal Vein / Q000601:surgery*; D012189:Retrospective Studies; D016019:Survival Analysis; D016896:Treatment Outcome